Logo
x

Search category

Subscribe Now

All Posts by Date

PharmaShots' Most Read News of 2022

PharmaShots' Most Read News of 2022

  • January 2, 2023
Hansa Biopharma Receives Positive Reimbursement Decision for Idefirix (imlifidase) in the Czech Republic

Hansa Biopharma Receives Positive Reimbursement Decision for Idefirix (imlifidase) in the Czech Republic

  • January 2, 2023
Legend Biotech Reports NMPA’s Acceptance of NDA for Ciltacabtagene Autoleucel (Cilta-Cel) in Multiple Myeloma

Legend Biotech Reports NMPA’s Acceptance of NDA for Ciltacabtagene Autoleucel (Cilta-Cel) in Multiple Myeloma

  • January 2, 2023
Everest Medicines and Calliditas Receives Priority Review for Nefecon in IgA Nephropathy for China

Everest Medicines and Calliditas Receives Priority Review for Nefecon in IgA Nephropathy for China

  • January 2, 2023
BeiGene Reports the NMPA’s Acceptance of sBLA for Tislelizumab for 1L Treatment of Hepatocellular Carcinoma

BeiGene Reports the NMPA’s Acceptance of sBLA for Tislelizumab for 1L Treatment of Hepatocellular Carcinoma

  • January 2, 2023
OncoC4 Reports First Patient Dosing of ONC-392 + Keytruda (pembrolizumab) in P-II Study (PRESERVE-004) for Platinum-Resistant Ovarian Cancer

OncoC4 Reports First Patient Dosing of ONC-392 + Keytruda (pembrolizumab) in P-II Study (PRESERVE-004) for Platinum-Resistant Ovar...

  • January 2, 2023
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.